Notice2023-19019
Notice of Public Meeting of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 5, 2023
Issuing agencies
State Department
Abstract
In accordance with the Federal Advisory Committee Act, the U.S. Department of State announces that the PEPFAR Scientific Advisory Board (SAB) will hold a virtual meeting of the full board. The meeting is open to the public and a public comment session will be held during the meeting. Pre-registration is required for providing public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 170 (Tuesday, September 5, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 170 (Tuesday, September 5, 2023)]
[Notices]
[Page 60731]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19019]
-----------------------------------------------------------------------
DEPARTMENT OF STATE
[Public Notice:12164]
Notice of Public Meeting of the U.S. President's Emergency Plan
for AIDS Relief (PEPFAR) Scientific Advisory Board
SUMMARY: In accordance with the Federal Advisory Committee Act, the
U.S. Department of State announces that the PEPFAR Scientific Advisory
Board (SAB) will hold a virtual meeting of the full board. The meeting
is open to the public and a public comment session will be held during
the meeting. Pre-registration is required for providing public comment.
DATES: The meeting will be held virtually Monday, October 2, 2023, from
approximately 9:00 a.m. to 3:00 p.m. (EDT) using a web-based virtual
platform. Requests to attend the meeting must be received no later than
September 25, 2023. Requests for reasonable accommodations or to
provide public comment must be received no later than September 25,
2023.
ADDRESSES: The meeting will be held virtually via web-based virtual
platform. Individuals are asked to pre-register here: <a href="https://statedept.zoomgov.com/meeting/register/vJItduChrTkrHOg_6xa7hBM0O6nxJptBtAc">https://statedept.zoomgov.com/meeting/register/vJItduChrTkrHOg_6xa7hBM0O6nxJptBtAc</a>. The agenda will be sent to all
registrants and will also be posted on the PEPFAR SAB web page (<a href="https://www.state.gov/scientific-advisory-board-pepfar/">https://www.state.gov/scientific-advisory-board-pepfar/</a>) one week in advance
of the meeting, along with instructions on how to access the meeting.
FOR FURTHER INFORMATION CONTACT: Dr. Mike Reid, Chief Science Officer
for PEPFAR, at <a href="/cdn-cgi/l/email-protection#2f5d4a464b42456f5c5b4e5b4a01484059"><span class="__cf_email__" data-cfemail="5b293e323f36311b282f3a2f3e753c342d">[email protected]</span></a>, and Dr. Nicole Espy, designated
federal officer for the SAB, Bureau of Global Health Security and
Diplomacy, U.S. Department of State, at <a href="/cdn-cgi/l/email-protection#7d180e0d0413173d0e091c0918531a120b"><span class="__cf_email__" data-cfemail="ec899f9c958286ac9f988d9889c28b839a">[email protected]</span></a> or (202) 288-
1702.
SUPPLEMENTARY INFORMATION:
Background: The SAB is established under the general authority of
the Secretary of State and the Department of State (``the Department'')
as set forth in title 22 of the United States Code as amended, in
particular section 2656 of that title, and consistent with the Federal
Advisory Committee Act, as amended (5 U.S.C. 1001 et seq). The SAB
serves the U.S. Global AIDS Coordinator solely in an advisory capacity
concerning scientific, implementation, and policy issues related to the
global response to HIV/AIDS.
Agenda: SAB members will be discussing the management of non-
communicable diseases (NCDs) among people with HIV, and integration of
NCD with HIV programming; updates in HIV prevention science, and roll
out of long-acting cabotegravir (CAB-LA); and PEPFAR 2023 strategic
updates and the launch of the new Bureau of Global Health Security and
Diplomacy (GHSD):
<bullet> Relevance of management of cardiovascular disease in HIV
care;
<bullet> Integration of NCD care into HIV programs;
<bullet> Updates on prevention science;
<bullet> Updates on launch of GHSD bureau and impact on PEPFAR's
mandate and programs.
Registered members of the public will be permitted to participate
in a comment period at the end of the meeting in accordance with the
chair's instructions.
Public Participation: Members of the public who wish to participate
are asked to register directly at the link listed in the ADDRESSES
section or by sending an email to Ms. Crystal Solomon at
<a href="/cdn-cgi/l/email-protection#4615292a292b2928050206353227322368212930"><span class="__cf_email__" data-cfemail="8ad9e5e6e5e7e5e4c9cecaf9feebfeefa4ede5fc">[email protected]</span></a> no later than September 25, 2023. Individuals are
required to provide their name, email address, and organization. At
registration, individuals are also asked to indicate any request for
reasonable accommodation and/or a request to provide public comment.
Time for public comment may be limited. Requests made after September
25, 2023, will be considered but might not be able to be fulfilled.
Nicole J. Espy,
Research and Technical Advisor, Office of Research and Science, Bureau
of Global Health Security and Diplomacy, Department of State.
[FR Doc. 2023-19019 Filed 9-1-23; 8:45 am]
BILLING CODE 4710-10-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 5, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.